FDA approves new type 2 diabetes treatment
The new drug treatment Tradjenta (linagliptin), used with diet and exercise, has been approved to help improve blood glucose control in adults with type 2 diabetes.
Blood pressure medicines may affect breast cancer recurrence
Preliminary study findings show ACE inhibitors increased the risk of breast cancer recurrence in patients, but beta blockers seemed to reduce the risk. When combining the two types of drugs, the beta blockers seemed to reduce the risk linked with ACE inhibitors.
Drug linked to bladder cancer
Reports are indicating more potential links to people taking the diabetes drug Actos to being at higher risk for developing bladder cancer.
FDA approves drug for Hepatitis C
Victrelis (boceprevir) has been approved to treat certain adults with chronic hepatitis C, including those who have not been treated with drug therapy for their hepatitis C, and may be used in combination with peginterferon alfa and ribavirin.
Should the DNP be required for licensure as a nurse practitioner?
Take our Quick Poll at www.tnpj.com and let us know your thoughts!
Gout diagnosis and management: What NPs need to know
Eva Hardy, MSN, RN, APN-BC
Earn 2.1 Contact Hours
Over-the-counter medications & pregnancy: An integrative review
Lori A. Cabbage, MSN, CNM, FNP, and Jeremy L. Neal, PhD, CNM, RN
Earn 2.5 Contact Hours
Giving responsibility to the patient
Jamesetta Newland, PhD, RN, FNP-BC, FAANP, FNAP